---
import Section from "../components/Section.astro";
import Layout from "../layouts/Layout.astro";
import SimpleHero from "../components/SimpleHero.astro";
import OneSource from "../components/OneSource.astro";
---

<Layout title="About Koselugo">
    <div class="wrapper about-koselugo">
        <SimpleHero folder="about-koselugo" alt="" />
        <Section>
          <Fragment slot="section-title">
            WHAT IS <span class="color-yellow">KOSELUGO?</span>
          </Fragment>
          <div class="wrapper">
            <h6>
              Koselugo is the FIRST and ONLY FDA-approved treatment shown to reduce the size of plexiform neurofibromas (PN)*
            </h6>
            <img class="custom-section__image" src="/assets/images/about/bottles_d.svg" alt=" ">
            <div class="wrapper wrapper--visit">
              <h4>Visit the Koselugo Frequently Asked Questions page</h4>
              <a href="https://koselugo.com/faqs" class="button button--basic">Visit the FAQs here</a>
              <a href="tel:+1888-765-4747" class="button button--basic button--only-mobile">Visit the FAQs here</a>
            </div>
          </div>
        </Section>
        <Section>
          <Fragment slot="section-title">
            CAN KOSELUGO HELP <span class="color-yellow">SHRINK PLEXIFORM TUMORS?</span>
          </Fragment>
          <div class="wrapper wrapper--primary">
            <h6>KOSELUGO HAS BEEN SHOWN TO SHRINK PLEXIFORM TUMORS IN CHILDREN AGED 2 YEARS AND OLDER</h6>
            <p>In a clinical study, Koselugo was proven to work for children with NF1 who have plexiform neurofibromas (PN) that cannot be completely removed by surgery:</p>
            <img class="custom-section__image custom-section__image--half" src="/assets/images/about/66-percent-pie-chart.svg" alt=" ">
          </div>
          <div class="wrapper wrapper--center-aligned">
            <h6>66% or 33 of 50 patients in the clinical study saw their plexiform neurofibromas (PN) shrink*</h6>
            <p>82% or 27 of 33 patients who responded continued to benefit for at least one year.</p>
          </div>
          <div class="wrapper wrapper--visit">
            <h5>What did people taking Koselugo treatment experience in a clinical study?</h5>
            <a href="https://koselugo.com/dosing-schedule#track-their-treatment" class="button button--basic">See their journeys</a>
          </div>
          <p class="custom-section__footnote">*Patients saw a 20% or more decrease in the size of their plexiform neurofibromas, confirmed by 3D magnetic resonance imaging scan.</p>
        </Section>
        <Section noHeader>
          <div class="wrapper wrapper--primary">
            <h6>IS THERE A SUPPORT PROGRAM TO HELP MY CHILD ACCESS TREATMENT?</h6>
            <h5>OneSource™ Support Services</h5>
            <img class="custom-section__image custom-section__image--half" src="/assets/images/about/personal-support-icon.svg" alt=" ">
          </div>
          <div class="wrapper">
            <h6>Your dedicated Patient Access Navigator is here to guide and give you the support you deserve—whatever your care plan may be. They can:</h6>
            <ul class="custom-section__list">
              <li class="custom-section__list-item">Answer questions about neurofibromatosis type 1 (NF1) plexiform neurofibromas (PN), Koselugo, your insurance coverage, and more</li>
              <li class="custom-section__list-item">Provide support during treatment</li>
              <li class="custom-section__list-item">Help you avoid interruptions in your child’s treatment during insurance changes, travel plans, or other life events</li>
              <li class="custom-section__list-item">Help you to get involved with the rare disease community through events and meetings</li>
            </ul>
          </div>
        </Section>
        <OneSource />
      </div>
</Layout>